Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
No open-market purchase by an insider of CME Group was filed in the last 90 days. The latest on record was on Mar 27, 2025.
How often do CME Group insiders buy and sell shares?
Since 2006, CME Group insiders reported 79 open-market purchases and 918 sales on Forms 4 and 5, with purchases in 15 different years, most recently 2025.
Who is selling CME Group stock?
In the last 90 days, 7 insiders of CME Group (CME) reported 8 open-market sales worth $9.71M in total on SEC Form 4. The largest seller by value was Terrence A Duffy, with $4.12M. Many insider sales follow a plan set in advance or cover taxes on stock awards; the filing says what was sold, not the reason.
Do members of Congress trade CME?
Yes. Members of Congress disclosed 5 trades in CME Group (CME) in the last 12 months, each reported as a value range on a periodic transaction report. The most recent are from Sen. Alan Armstrong, Rep. Gilbert Ray Cisneros Jr. (CA31), Rep. Julie Johnson (TX32).
When does CME Group report its next results?
CME Group's next results are expected on Feb 2, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
Where does this data come from?
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
CME price and disclosed activity
+11.1% (+$30.97) from Nov 18, 2025 to Nov 18, 2026 · adjusted daily closes
Adjusted close went from $279.28 on Nov 18, 2025 to $310.25 on Nov 18, 2026 (+11.1%). Disclosed in this range: 23 insider trades, 1 pre-arranged insider sale, 4 Congress trades, and 150 13F position changes for 4 quarters ending in it.
$200$250$350$310.25
DecJan 2026FebMarAprMayJunJulAugSepOctNov
13F holdings, by quarter end
Insider and Congress marks sit on the trade date stated in the filing; solid is a purchase, hollow a sale. A number means several trades too close to tell apart at this range: pick a shorter range or open it for the list. Fund 13F reports are quarter-end snapshots filed up to 45 days later, so they are shown under the chart across the quarter they describe, not on the price line. Congress amounts are official ranges; mark size uses the lower bound. Past moves are not a forecast.Show the 28 trades in this range as a list
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Financial Exchanges & Data company based in Chicago, Illinois.
Last 12 months
+11.1%
S&P 500 +10.6% over the same dates
Market value
$112B
Close of Nov 18, 2026 × shares outstanding (per ADS where it applies)
S&P 500 +10.6% over the same dates. Prices adjusted for splits and dividends.
Short interest: 5.35M shares sold short (1.5% of shares outstanding), +7.3% vs the previous count, 2.4 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Latest results: quarter ending Sep 30, 2026
Revenue
$1.74B
+13.0% vs the same quarter a year earlier
Free cash flow, last 12 months
$4.33B
This quarter $1.07B, a year earlier $950M
Net debt
—
Debt —, cash $2.2B, at Sep 30, 2026
Net income, last 12 months
—
Operating profit covers interest 26.2x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Oct 21, 2026.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 30 days
Written by software from the filings listed below · Nov 13, 2026
Insiders.CME Group on OQRO: In the 30 days to Nov 13, 2026, insiders filed 0 open-market purchases and 5 open-market sales. The largest sale was Julie Winkler, Sr MD Chief Commercial Officer, about $3.08M, filed Nov 3, 2026.
3 more points, with the facts they come from, are in OQRO Pro.
Insiders of CME Group reported 79 open-market purchases and 918 sales since 2006; purchases in 15 different years, most recently 2025.
Year
Bought
Sold
2026
—
$26.5M17×17 trades
2025
$3K1×1 trade
$33M30×30 trades
2024
$472K8×8 trades
$15.1M21×21 trades
2023
$497K11×11 trades
$18.8M23×23 trades
2022
$8.62M6×6 trades
$11.1M20×20 trades
2021
$441K7×7 trades
$26.7M44×44 trades
2020
$356K2×2 trades
$12.8M23×23 trades
2019
—
$41.2M45×45 trades
2018
—
$27.4M42×42 trades
2017
—
$20.7M51×51 trades
2016
$9.8K1×1 trade
$32.4M60×60 trades
2015
$2862×2 trades
$18M39×39 trades
2014
—
$12.6M51×51 trades
2013
$26K1×1 trade
$14.9M72×72 trades
2012
$762K5×5 trades
$4.11M28×28 trades
2011
$201K3×3 trades
$1.3M10×10 trades
2010
$2M6×6 trades
$8.48M44×44 trades
2009
$2.1K9×9 trades
$10.3M58×58 trades
2008
$2.81M16×16 trades
$12.4M56×56 trades
2007
—
$57.3M81×81 trades
2006
$4141×1 trade
$65M103×103 trades
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
OQRO Intelligence
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Insiders. In the 12 months to Nov 19, 2026, insiders of CME Group filed 0 open-market purchases (about $0, in 0 filings, by 0 people) and 21 open-market sales (about $35.2M, in 17 filings, by 13 people). One Form 4 can list many transactions. In the 12 months before that, they filed 1 open-market purchase (about $3K, in 1 filing) and 26 open-market sales (about $24.3M, in 21 filings). (CME Group on OQRO)
Congress. Members of Congress filed 5 disclosures on CME Group in the 12 months to Nov 19, 2026: 2 purchases and 3 sales, by 3 members. In the 12 months before that: 8 disclosures. The largest range: Rep. Julie Johnson (TX32), $1,001 to $15,000, filed Dec 11, 2025.
Funds and stakes. Fund 13F filings recorded in the 12 months show 72 new or larger positions and 79 smaller or closed positions. A 13F is a snapshot of holdings at the end of a quarter.
Contracts, lobbying and filings. 9 lobbying reports naming the company were posted in the 12 months, reporting about $1.81M. The Federal Register published a proposed rule, "Conflicts and Affiliations", on Aug 6, 2026, naming the company.
Company reports, price and press. CME Group filed a Form 8-K on Oct 21, 2026 (Item 2.02) that OQRO classes as: reported its results. CME Group filed a Form 8-K on Sep 9, 2026 (Item 5.02) that OQRO classes as: changed a top executive or board member.
Who holds it. 1,698 funds reported a stake in CME Group in their 13F for Q2 2026. The largest by value: BlackRock, Inc. (9.5% of the value reported), VANGUARD CAPITAL MANAGEMENT LLC (7.3% of the value reported), STATE STREET CORP (5.1% of the value reported).
Attention. The English Wikipedia article on CME Group was read about 175 times a day in the 7 days to Nov 18, 2026, against a usual 218 a day over the 90 days before. Reads measure attention, not buying or selling.
Things to keep in mind. These are counts of the filings OQRO holds, in the days they were filed; a busy or quiet month does not say why. A Form 4 reports a transaction; it does not say why it was made, and some follow trading windows or pre-arranged plans. Congress reports give only amount ranges and arrive after the trade. Total compensation in a proxy statement counts stock and option awards at their grant-date value, not what was sold.
Facts used for this text
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
In the 12 months to Nov 19, 2026, insiders of CME Group filed 0 open-market purchases (about $0, in 0 filings, by 0 people) and 21 open-market sales (about $35.2M, in 17 filings, by 13 people). One Form 4 can list many transactions.
In the 12 months before that, they filed 1 open-market purchase (about $3K, in 1 filing) and 26 open-market sales (about $24.3M, in 21 filings).
The largest sale: Terrence A Duffy, Chairman and CEO, about $7.75M, filed May 18, 2026.
Congress
Members of Congress filed 5 disclosures on CME Group in the 12 months to Nov 19, 2026: 2 purchases and 3 sales, by 3 members. In the 12 months before that: 8 disclosures.
The largest range: Rep. Julie Johnson (TX32), $1,001 to $15,000, filed Dec 11, 2025.
Funds and stakes
Fund 13F filings recorded in the 12 months show 72 new or larger positions and 79 smaller or closed positions. A 13F is a snapshot of holdings at the end of a quarter.
Contracts, lobbying and filings
9 lobbying reports naming the company were posted in the 12 months, reporting about $1.81M.
The Federal Register published a proposed rule, "Conflicts and Affiliations", on Aug 6, 2026, naming the company.
The Federal Register published a notice, "In the Matter of Nasdaq PHLX LLC; Order Granting Petition for Review and Scheduling Filing of Statements Regarding an Order Approving, on an", on Aug 3, 2026, naming the company.
FINRA short interest for CME on the settlement date of Oct 30, 2026 was 5,351,351 shares (+7.28% on the previous report), about 2.42 days of average volume.
In 13F filings for the quarter ended Sep 30, 2026, the largest positions that grew: Baupost Group (increased, 66,435 shares); the largest that shrank: Viking Global (sold out). A 13F is a quarter-end snapshot with no trade date.
For fiscal 2025, the company's proxy statement reported total compensation of $23.4M for its principal executive officer, and an average of $3.72M for the other named executive officers.
Company reports, price and press
CME Group filed a Form 8-K on Oct 21, 2026 (Item 2.02) that OQRO classes as: reported its results.
CME Group filed a Form 8-K on Sep 9, 2026 (Item 5.02) that OQRO classes as: changed a top executive or board member.
The company's own opening sentence of that report reads: "As described in the attached press release, CME Group Inc. ('CME Group' or the 'Company') announced new senior leadership appointments in its finance and legal divisions."
CME Group filed a Form 8-K on Jun 17, 2026 (Items 5.02, 7.01) that OQRO classes as: changed a top executive or board member, and shared information with investors.
The company's own opening sentence of that report reads: "On June 17, 2026, CME Group Inc. (the 'Company') announced that Terrence A. Duffy, the Company’s current Chairman and Chief Executive Officer, will become the Company’s Executive Chairman, and Lynne C. Fitzpatrick, the Company’s..."
Press coverage listed by Finnhub: "CME Group Announces First Trade for Wind Power Contracts" (Yahoo, Nov 19, 2026).
Press coverage listed by Finnhub: "'Nuclear Revival Spurs CME to Move Ahead on Physical Uranium Contracts' - Bloomberg Exclusive" (Benzinga, Nov 11, 2026).
Press coverage listed by Finnhub: "CME Group Declares Quarterly Dividend" (Yahoo, Nov 5, 2026).
CME closed at $310.25 on Nov 18, 2026, the last session on or before the end of the period.
From Oct 19, 2026 to Nov 18, 2026, the close moved from $293.53 to $310.25, a change of +5.7%.
Who holds it
1,698 funds reported a stake in CME Group in their 13F for Q2 2026. The largest by value: BlackRock, Inc. (9.5% of the value reported), VANGUARD CAPITAL MANAGEMENT LLC (7.3% of the value reported), STATE STREET CORP (5.1% of the value reported).
Attention
The English Wikipedia article on CME Group was read about 175 times a day in the 7 days to Nov 18, 2026, against a usual 218 a day over the 90 days before. Reads measure attention, not buying or selling.
Things to keep in mind
These are counts of the filings OQRO holds, in the days they were filed; a busy or quiet month does not say why.
A Form 4 reports a transaction; it does not say why it was made, and some follow trading windows or pre-arranged plans. Congress reports give only amount ranges and arrive after the trade.
Total compensation in a proxy statement counts stock and option awards at their grant-date value, not what was sold.
An 8-K item says what the company reported, not what it means for the share price.
Headlines are listed as published by the outlets; OQRO has not checked them and does not summarise articles.
Share price moves are listed as context only; the filing does not explain them and other news can move a price.
This describes public filings. It is not investment advice.
Federal rules, proposed rules and notices that name the company by its legal name, from the Federal Register. Being named is not the same as being the target of a rule.
When insiders usually buy
Last results
Oct 21, 2026
Within the 30 days after it, until Nov 20, 2026
Next results, expected
Feb 2, 2027
after the market closes; the date can move until the company confirms it
Purchases after results
26%
9 of 35 insider purchases since 2018 came within 30 days after a results announcement
From CME Group's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know CME Group's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
Legal
A securities lawsuit naming the company as a defendant was filed on Jun 14, 2024 in the U.S. District Court, S.D. New York. A filing is an allegation, not a finding.
Federal civil cases with nature of suit 850 (securities) filed in the last 3 years where the company is the first named defendant, from court records on CourtListener (Free Law Project). Coverage of court records is not complete, and shareholder derivative suits are not included.
People read CME Group's Wikipedia article about 170 times a day over the last week, close to the 220 on a usual day of the three months before.
May 14, 2026Busiest day: 590 views on Jun 17, 2026Nov 18, 2026
Views of the article CME Group, by people (Wikimedia leaves out known bots). More readers means more attention, from news, results or anything else; it does not say anyone bought or sold. Source: Wikimedia pageviews.
Risk factors in the annual report
Latest annual report filed Feb 26, 2026, compared with the one filed Feb 27, 2025. Read the filing
New risk factors in the latest annual report (2 headings)
Our business is subject to the impact of financial markets volatility, which is caused by conditions that are beyond our control.
Our use of artificial intelligence in our business may be unsuccessful and may give rise to various risks, which could adversely affect our business, reputation or operating results.
Legal proceedings (Item 3)
See "Legal and Regulatory Matters" in note 12. Contingencies to the consolidated financial statements beginning on page 77 for CME Group’s legal proceedings disclosure, which is incorporated herein by reference.
The company describes its cases in the notes to its financial statements, in the same filing.
Source: SEC EDGAR, Form 10-K filed Feb 26, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
Short sale volume: 41.4% of the volume reported to FINRA over the last 20 trading days was marked short, close to its 1-year average of 40.6%. FINRA daily files, to Nov 18, 2026.
Fails to deliver: 10K shares (about $3.05M) were not delivered on time for settlement on Oct 28, 2026. SEC fails-to-deliver data.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock. Fails to deliver have many causes, including processing delays, and are often resolved within days.
Off-exchange trading: 44.1% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (27.9% on ATS, 16.2% with other brokers), close to its 26-week average of 43.9%. Weeks of Oct 5 to Oct 30, 2026.
Week of May 4ATSOther off-exchangeFull height = all shares tradedWeek of Oct 26
Largest ATS: INTELLIGENT CROSS LLC (12.8%), UBS ATS (12.6%), SIGMA X2 (12.3%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.
Since Nov 17, 2025, CME is up 11.1% and the index fund is up 9.7%: 1 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much CME moves
A usual day
±1.0%Half of the sessions moved less than this, half moved more.
Daily range (ATR 14)
2.2%Average distance between the low and the high of a session, over the last 14.
Largest one-day fall
−5.8%Jun 1, 2026
Largest one-day rise
+5.0%Jul 22, 2026
Deepest fall of the year
−33.0%From the close of Mar 2, 2026 to Jun 29, 2026.
Days of 5% or more
1Out of 252 sessions, in either direction.
Beta −0.3(1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 251 trading days (1 = in step with it).